Calibrate
PrivateLast Round
Private Equity
Nov 1, 2023
Total Funding Raised
$194.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Calibrate operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Private Equity round in November 2023.
Calibrate is a health technology company that provides a weight management platform aimed at enhancing metabolic health through telemedicine, personalized coaching, and behavior change strategies for sustainable weight loss.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Sports & Fitness
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Calibrate Comparables
Compare Calibrate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Form Health | 84% | |
| 9amHealth | 84% | |
| Omada Health, Inc. | 84% |
For institutional investors. Book with your work email.
Calibrate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Nov 1, 2023 | ||||
| Debt | Nov 8, 2022 | ||||
| Series B | Aug 25, 2021 | ||||
| Series A | Jan 26, 2021 | ||||
| Seed | Jun 24, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Calibrate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Threshold Ventures | Series B, Series A |
| Forerunner Ventures | Series B, Series A, Seed |
| M13 | Series B |
| Gaingels | Series B |
| Founders Fund | Series B |
| Madryn Asset Management | Debt, Private Equity |
| Optum Ventures | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 166% MoM.
- Jul 28, 2026
Monthly visitors grew 60% MoM, from 1.3K to 2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueSep 2, 2026
Calibrate Health, Inc. reaches $69.7M in revenue in Sep '25.
For institutional investors. Book with your work email.
Calibrate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Calibrate's valuation, stock price, and market status.
Is Calibrate a public or private company?
Calibrate is a private company.
What is the current stock price of Calibrate?
Calibrate is a private company, so its shares have no public market price. Caplight tracks Calibrate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Calibrate worth (valuation)?
Valuation information for Calibrate is not publicly available.
Can I buy Calibrate stock?
Calibrate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Calibrate's last funding round?
Calibrate's most recent funding round was Private Equity on November 1, 2023.
Who are the main investors in Calibrate?
Key investors in Calibrate include Threshold Ventures, Forerunner Ventures, Founders Fund, Madryn Asset Management, Tiger Global Management.
Will Calibrate IPO soon?
No public IPO plans have been announced for Calibrate.
How can I track Calibrate secondary market activity?
Caplight tracks bids, offers, and trades in Calibrate's shares on secondary markets.